Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers

Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers

Chemotherapy resistance is a huge barrier for head and neck cancer (HNC) patients and therefore requires close attention to understand its underlay mechanisms for effective strategies. In this review, we first summarize the molecular mechanisms of chemotherapy resistance that occur during the treatm...

Full description

Bibliographic Details
Main Authors:	Yuzuka Kanno, Chang-Yu Chen, Hsin-Lun Lee, Jeng-Fong Chiou, Yin-Ju Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Oncology
Subjects:	head and neck cancer chemotherapy resistance chemotherapy immunotherapy combination therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.640392/full

Similar Items

A Combined Systemic Strategy for Overcoming Cisplatin Resistance in Head and Neck Cancer: From Target Identification to Drug Discovery
by: Yin-Ju Chen, et al.
Published: (2020-11-01)

Effects of Exercise in Patients Undergoing Chemotherapy for Head and Neck Cancer: A Pilot Randomized Controlled Trial
by: Kuan-Yin Lin, et al.
Published: (2021-02-01)

Recent advances in chemotherapy for head and neck cancers
by: Uma C Sambargi, et al.
Published: (2012-01-01)

Insonation of Systemically Delivered Cisplatin-Loaded Microbubbles Significantly Attenuates Nephrotoxicity of Chemotherapy in Experimental Models of Head and Neck Cancer
by: Hang-Kang Chen, et al.
Published: (2018-09-01)

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study
by: Ching-Yun Hsieh, et al.
Published: (2020-09-01)

The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction
by: Chen-Hsiang Kuan, et al.
Published: (2020-10-01)

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
by: Chien Chih-Yen, et al.
Published: (2011-03-01)

Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
by: Petr Szturz, et al.
Published: (2016-08-01)

Effect of Exercise Training on Exercise Tolerance and Level of Oxidative Stress for Head and Neck Cancer Patients Following Chemotherapy
by: Chia-Jui Yen, et al.
Published: (2020-08-01)

The Effect of Hypnotherapy on Anticipatory Nausea in Head and Neck Cancer Patients Undergoing Chemotherapy
by: Dadi Hamdani, et al.
Published: (2020-12-01)

Therapeutic methods used in the treatment of malignant lymphomas of the head and neck
by: Mihail TUȘALIU, et al.
Published: (2018-09-01)

Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer
by: Hung-Ming Wang, et al.
Published: (2017-03-01)

Carbon‐ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study
by: Yukihiro Takayasu, et al.
Published: (2019-12-01)

The Efficacy and Adverse Events in Patients with Head and Neck Cancer Following Radiotherapy Combined with S-1 Therapy: A Meta-Analysis
by: Hung-Sheng Shih, et al.
Published: (2021-06-01)

RADIOCHEMOTHERAPY FOR ADVANCED HEAD AND NECK CARCINOMA – LJUBLJANA EXPERIENCE
by: Lojze Šmid, et al.
Published: (2002-12-01)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
by: Daris Ferrari, et al.
Published: (2020-01-01)

Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database
by: Xinrong Li, et al.
Published: (2020-11-01)

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers
by: Sandra Ortiz-Cuaran, et al.
Published: (2021-02-01)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
by: Muhammad Furqan, et al.
Published: (2019-06-01)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2020-01-01)

STUDY OF THE ROLE OF COMBINED RADIOTHERAPY & CHEMOTHERAPY IN TREATMENT OF SQUAMOUS CELL TUMORS OF HEAD AND NECK
by: A MOSALAEI
Published: (2003-12-01)

Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics
by: Łukasz Boguszewicz, et al.
Published: (2021-04-01)

Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma
by: Wei-Shan Chen, et al.
Published: (2021-09-01)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
by: Valerie Cristina, et al.
Published: (2019-10-01)

Pharmacokinetic-Based Chemotherapy Dosing in Advanced Head and Neck Cancer: A Mini Review
by: Abdelhamid Fouad, et al.
Published: (2019-06-01)

Blood neutrophil-to-lymphocyte ratio as a predictor of response to chemotherapy in head-and-neck cancers
by: Mohammad Hashemi-Bahremani, et al.
Published: (2019-01-01)

Evaluation of head and neck cancer patients’ knowledge regarding complications of chemotherapy and radiotherapy in patients referring to Kerman University of Medical Sciences treatment centers
by: Molook Torabi Parizi, et al.
Published: (2018-09-01)

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma
by: Sjoukje F. Oosting, et al.
Published: (2019-08-01)

The Indian scenario of head and neck oncology - Challenging the dogmas
by: Vidisha Tuljapurkar, et al.
Published: (2016-01-01)

Indications and outcomes of superselective neck dissection: A review and analysis of the literature
by: Avanti Verma, et al.
Published: (2020-08-01)

Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas
by: Vanessa de Carvalho Fabrício, et al.

Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
by: Akash Mathur, et al.
Published: (2018-01-01)

Safety and Efficacy of Salvage Neck Dissection Following Carbon-ion Radiotherapy with Chemotherapy for a Patient with Mucosal Malignant Melanoma of Head and Neck
by: Hidenori Suzuki, et al.
Published: (2020-02-01)

An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
by: Vijay M Patil, et al.
Published: (2016-01-01)

Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases
by: Aline Houessinon, et al.
Published: (2020-07-01)

Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
by: Vijay M Patil, et al.
Published: (2016-01-01)

In vitro chemosensitivity of head and neck cancer cell lines
by: Schuler PJ, et al.
Published: (2010-08-01)

The Impact of Active Nutritional Support for Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
by: Vutisiri Veerasarn, et al.
Published: (2019-12-01)

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study
by: Pergolizzi Stefano, et al.
Published: (2011-11-01)

Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise
by: Tatsuya Ito, et al.
Published: (2021-06-01)